Advarra Launches Study Collaboration Solution to Accelerate Clinical Trial Startup

by Roman Kasianov       News

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

  
Topics: Clinical Trials   
Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email   |  

Advarra, a provider of regulatory review solutions and clinical research technology, has introduced its Study Collaboration solution, designed to streamline site activation workflows, improve stakeholder engagement, and enhance visibility across clinical trials. The new offering combines Advarra’s Longboat technology, acquired in 2020, with its study startup delivery program and single sign-on capabilities, aiming to reduce delays in trial timelines.

The solution includes two integrated products: Advarra Study Startup (SSU) and Advarra Enroll. Together, they automate critical processes such as feasibility assessments, document exchange, site training, milestone tracking, and enrollment planning. By centralizing these workflows, the platform aims to shorten the time from site selection to patient recruitment.

Ashley Davidson, Vice President and Product Lead at Advarra, commented:

“Study startup remains one of the most challenging aspects of clinical trials, with manual processes and disconnected systems often causing delays. Our Study Collaboration solution addresses these inefficiencies by automating workflows and improving visibility, helping trials meet enrollment goals and bring new treatments to patients faster.”

The launch builds on Advarra’s ongoing efforts to enhance clinical trial efficiency. In July 2024, the company introduced centralized patient recruitment oversight within its Longboat platform, providing sponsors and CROs with real-time visibility into recruitment activities. Early data showed that trials using Longboat were 27% more likely to meet recruitment targets, addressing one of the most persistent challenges in clinical research.

The Study Collaboration solution also addresses site-specific challenges, such as fragmented workflows and redundant tasks. Nancy Cleverley, Senior Vice President of Operations Management at the Alliance for Multispecialty Research (AMR), highlighted the platform’s ability to simplify document routing between sponsors’ and sites’ systems, saving time and improving compliance.

Topics: Clinical Trials   

Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email